MISSISSAUGA, ON, Jan. 7, 2026 /CNW/ — Abbott’s (NYSE: ABT) newest sensor-based glucose technology, the FreeStyle Libre 3 Plus * sensor, is now publicly funded in every province across Canada vi, in ...
Abbott is tapping the spirit of new beginnings for the New Year by unveiling a “gamechanger" feature within the company’s Libre app: Libre Assist. Timed to launch during this week’s CES 2026 ...
The Libre Assist feature. [Image courtesy of Abbott] Abbott (NYSE:ABT) today unveiled a new feature within its Libre app for continuous glucose monitoring (CGM). Libre Assist, the new feature, aims to ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results